COGSTATE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.12 AUD | 0.00% |
|
+2.28% | -22.49% |
| 01/04 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| 22/02 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
Evolution of the average Target Price on Cogstate Limited
Price target over the last 5 years
History of analyst recommendation changes
5.gHLIhY5sgeleG-R3YGEdXWKF-IKzazNQGSgynfrUwoo.yTOu3csY2bo1Y70xN1goZDTRkMiAP3gxX2B504ORi-DwG6vD9zay2TErrQ~2a127c5df1ad85b5867cf2ba7d293941
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.12
AUD
Average target price
1.8
AUD
Spread / Average Target
+60.71%
High Price Target
1.8
AUD
Spread / Highest target
+60.71%
Low Price Target
1.8
AUD
Spread / Lowest Target
+60.71%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CGS Stock
- Consensus Cogstate Limited
